Cigna Investments Inc Regeneron Pharmaceuticals, Inc. Transaction History

Cigna Investments Inc

  • $538 Million
  • Q1 2025

A detailed history of Cigna Investments Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cigna Investments Inc holds 1,052 shares of REGN stock, worth $515,774. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,052
Previous 1,078 2.41%
Holding current value
$515,774
Previous $768,000 13.15%
% of portfolio
0.12%
Previous 0.13%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$634.14 - $744.83 $16,487 - $19,365
-26 Reduced 2.41%
1,052 $667,000
Q4 2024

Jan 29, 2025
SELL
$701.85 - $1046.91 $6,316 - $9,422
-9 Reduced 0.83%
1,078 $768,000
Q3 2024

Oct 28, 2024
SELL
$1024.09 - $1201.76 $15,361 - $18,026
-15 Reduced 1.36%
1,087 $1.14 Million
Q2 2024

Jul 17, 2024
BUY
$883.2 - $1071.19 $5,299 - $6,427
6 Added 0.55%
1,102 $1.16 Million
Q1 2024

Apr 23, 2024
SELL
$902.69 - $993.35 $5,416 - $5,960
-6 Reduced 0.54%
1,096 $1.06 Million
Q4 2023

Jan 22, 2024
SELL
$775.18 - $881.7 $13,178 - $14,988
-17 Reduced 1.52%
1,102 $967,000
Q3 2023

Oct 23, 2023
SELL
$692.45 - $844.37 $109,407 - $133,410
-158 Reduced 12.37%
1,119 $921,000
Q2 2023

Aug 01, 2023
BUY
$700.03 - $830.35 $3,500 - $4,151
5 Added 0.39%
1,277 $918,000
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $17,692 - $21,501
-26 Reduced 2.0%
1,272 $1.05 Million
Q4 2022

Feb 13, 2023
BUY
$705.89 - $766.39 $2,823 - $3,065
4 Added 0.31%
1,298 $937,000
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $31,568 - $39,837
-55 Reduced 4.08%
1,294 $891,000
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $268,143 - $361,292
-489 Reduced 26.61%
1,349 $798,000
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $317,198 - $372,263
-533 Reduced 22.48%
1,838 $1.28 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $468,479 - $578,376
-862 Reduced 26.66%
2,371 $1.5 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $63,717 - $75,586
-111 Reduced 3.32%
3,233 $1.96 Million
Q2 2021

Aug 10, 2021
SELL
$472.8 - $558.54 $190,538 - $225,091
-403 Reduced 10.76%
3,344 $1.87 Million
Q1 2021

May 10, 2021
BUY
$446.73 - $548.2 $9,381 - $11,512
21 Added 0.56%
3,747 $1.77 Million
Q4 2020

Feb 11, 2021
BUY
$478.3 - $607.98 $182,710 - $232,248
382 Added 11.42%
3,726 $1.8 Million
Q3 2020

Nov 12, 2020
SELL
$544.75 - $658.21 $16,342 - $19,746
-30 Reduced 0.89%
3,344 $1.87 Million
Q2 2020

Aug 17, 2020
BUY
$493.32 - $643.92 $509,106 - $664,525
1,032 Added 44.06%
3,374 $2.1 Million
Q1 2020

May 11, 2020
BUY
$336.18 - $494.43 $50,427 - $74,164
150 Added 6.84%
2,342 $1.14 Million
Q4 2019

Feb 04, 2020
SELL
$274.13 - $376.51 $60,856 - $83,585
-222 Reduced 9.2%
2,192 $741,000
Q3 2019

Nov 07, 2019
BUY
$273.46 - $318.39 $27,345 - $31,839
100 Added 4.32%
2,414 $739,000
Q2 2019

Aug 12, 2019
SELL
$299.6 - $414.82 $20,972 - $29,037
-70 Reduced 2.94%
2,314 $705,000
Q1 2019

May 10, 2019
BUY
$372.08 - $439.57 $7,069 - $8,351
19 Added 0.8%
2,384 $978,000
Q4 2018

Feb 06, 2019
SELL
$335.82 - $403.04 $20,149 - $24,182
-60 Reduced 2.47%
2,365 $883,000
Q3 2018

Nov 13, 2018
SELL
$351.14 - $408.51 $43,190 - $50,246
-123 Reduced 4.83%
2,425 $822,000
Q2 2018

Aug 14, 2018
SELL
$284.6 - $344.99 $111,563 - $135,236
-392 Reduced 13.33%
2,548 $879,000
Q1 2018

May 09, 2018
SELL
$315.82 - $393.78 $19,265 - $24,020
-61 Reduced 2.03%
2,940 $1.01 Million
Q4 2017

Jan 26, 2018
SELL
$358.63 - $469.95 $40,883 - $53,574
-114 Reduced 3.66%
3,001 $1.13 Million
Q3 2017

Oct 11, 2017
BUY
$431.38 - $504.0 $1.34 Million - $1.57 Million
3,115
3,115 $1.39 Million

Others Institutions Holding REGN

# of Institutions
1,471
Shares Held
85.8M
Call Options Held
1.39M
Put Options Held
1.45M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $52.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cigna Investments Inc Portfolio

Follow Cigna Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email